Skip to main content

Table 5 Oversight committee split by intervention type

From: A cohort examination to establish reporting of the remit and function of Trial Steering Committees in randomised controlled trials

Intervention type TSC reported DMC reported
Yes No Yes No
  N n n/N% n n/N% n n/N% n n/N%
Pharmaceutical 132 68 51.5% 64 48.5% 97 73.5% 35 26.5%
Cellular and gene therapy 3 0 0.0% 3 100.0% 2 66.7% 1 33.3%
Medical device 26 17 65.4% 9 34.6% 19 73.1% 7 26.9%
Surgery 14 9 64.3% 5 35.7% 9 64.3% 5 35.7%
Radiotherapy 13 7 53.8% 6 46.2% 5 38.5% 8 61.5%
Psychological and behavioural 29 14 48.3% 15 51.7% 11 37.9% 18 62.1%
Physical 14 11 78.6% 3 21.4% 8 57.1% 6 42.9%
Complimentary 6 3 50.0% 3 50.0% 2 33.3% 4 66.7%
Resources and infrastructure 22 13 59.1% 9 40.9% 5 22.7% 17 77.3%
Other 19 13 68.4% 6 31.6% 7 36.8% 12 63.2%
  1. DMC Data Management Committee, TSC Trial Steering Committee